pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-488 |
Genomic Coordinates | chr1: 177029363 - 177029445 |
Synonyms | MIRN488, hsa-mir-488, MIR488 |
Description | Homo sapiens miR-488 stem-loop |
Comment | miR-488-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-488-3p | |||||||||||||||||||||
Sequence | 52| UUGAAAGGCUAUUUCUUGGUC |72 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAM169A | ||||||||||||||||||||
Synonyms | SLAP75 | ||||||||||||||||||||
Description | family with sequence similarity 169 member A | ||||||||||||||||||||
Transcript | NM_015566 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAM169A | |||||||||||||||||||||
3'UTR of FAM169A (miRNA target sites are highlighted) |
>FAM169A|NM_015566|3'UTR 1 AGGAAGAAGAAAGTGGATGATAAATCCTCTTCTTTGTAACATAGTTGTTGTTTTTAAAATATGGTAATTAATAAACAGCA 81 TGGGGCACAGGACAAAAATTTCCAAAATTTCAATTTGAACTTACTTACTATGCAGTTTTTTGCTTCCCTTTAGAACGTAG 161 AATTCACCATTGTTTTTAATTTTCCAGGCTATTTTTGGTAAATGCAATTTTTTATTTTTATTAACCATGTTTCAATTTTG 241 GGAAACCAGATCATATTATATTTTCTTTATCAGGTGGTACATCTGACCATTATTTCAAAAATATAATTAAAAAGCTGTGA 321 AAGTAGTAGGATTTCCATTACTTATAAGGATCACAGAAATCTTTTATACTAAGGGTTTTAATAGTAAAACTTGGTGAGGG 401 TTCTAGAAGTTTTAAATTTCAAAACTAATCACCAATTTTTTAAAATGTAGGCATGCCTAAACAAAAATAAGTGTCAATAA 481 ATTAGAAAAAATATAACTTCAAGTAAATGAGAGCACAAAAACAGAAACTTACGGTCAAAGGTTCATGAAGATATTTTGGT 561 TTTGGCCTCTTAATCCTAGATATAGATGCAGTTTTTTCCTTTGACTTCACTATCTATGGAAAGGTACACATAAAATCTGT 641 TTCTGATTCATTCTATCATCTGATGTTAACAGTACTGTCAGGGATTTAACTGTGGCATGTGGGGACTAATTATTTAAAAT 721 TTCATTTGAAGTATTAGTTTGCTGTAATTTTTTTTGTCTGCATATGTGCAGACGCCTAGAAGTTTAGACTTTCACCTTTA 801 ATCAGGTAAAAATCACAACTATACTTTGGAGACATGGTTTAATTTGGACTTCTGGTCCTGATCAGATAGATAAATTAAGC 881 TGGAGATTTTACTTTTATCCCAACCCAGTTAACATCTATATTTCAGAAGTATGAGGCTCCTTCCTAAGGCATCTCCTTAA 961 ATCTTGCCACCTCCCTAATTCTACAGTCTTATTTATATTCCCCCACAGCTTTCATCTACTTCTGTAACTCATGGAGTGAT 1041 TCTCCAATCAACAGATCTTCCTGCCTGCCGGCTTATGCCCTTGATGTCCATTTTTGGGTAGGTTTGGAGGTGCACCCCAC 1121 AATGTTAGACCTATATGGCAGGAGTAAAACTGCCCCCAGTGTTAGACCTATATGGCAGGGGTAAACTGCCTTTGGGGGAG 1201 CTGTGGTTACAAGGGCTTCAATCATATTGGAGGCTTCAATCATCCTTTGATTTGTACTGAGTACTGGTTGCAAGCTGGCC 1281 TGTTAAGTATATATTGTGTTGCCATAACAAAGGCCTAGGAAAATTTGAAGAAAAAAAACACTGAACTGTTATTTTTTGTA 1361 ATTTATTTAAAAATGGACAAAATGGTTATTAGAATCCAAAGATAATCTAAAAACAGTTCTACTCTTTGGAAATATTATGT 1441 GTACTCAAATTTGCACTTAAGTTGGAGAATGTTTTGAGACCATTTAAATTGTTTTAAAAATAGCTTGATCTTGATCCTTA 1521 TGCAAAAGAAACTAAGACTTTGTGTCATTATTTGAGGTAGCTAAGGACTGATGTTGAAAGTGTATTCAGTCTATAGTAAG 1601 CTGATGTCAGGTCAGTAAATTTTGTTTGGGGATGTTGGTATTTTCGATCAAGTTAAAATCTTAAAGCAGACAAAAATAGT 1681 AAACGCTCCTATTTGTGTTAGATTTTGAACAATTGTATTACCCTATATTTTCTTTAATTAGTCAAAGGTAAGCCAGATTA 1761 TTTCATTCTAAATGAAAATTAAAGCACTTTGGCCATTTATTTTTTCAACAAATGCTAATACTAAGTAAAAAAAAAAAAGT 1841 ATGACTACTATTAGTGAATCTACCAAACATTTATGCTGTTTTATACATTTTATGAGAAACTTCTGTCAATATCACAAAGG 1921 GAAATACTCTGTTAAGATTCAGTAAATTCTTAATCTTTACATGTTTCATTTCTTAGATTTGAAAACACTTGTAGATATTT 2001 TATTTTTACTTGGATTTGTTTAAAATACTTTCTTTTCAAATTATTTTAAACATGGAAACGCTTCATGAATTTGTGTCATC 2081 CTTGCACAGGGGCCATGCTAATTTTCCCTGTATTGTTCTAATTTTAGTATATGTGCTGCCGAAGTGAGCACTAAAAGACT 2161 TTCTTTAGACAAGTGTAGTTTTTTAAAGATTGAGCTCACTGGCTCAACTCTTGATGTGTGAATATAGTTGAGTTTACAAA 2241 AAATGTTTATTAATCATATATGACCATTGGGGGCTAACAGTATAAACTTATTCTTGTTAAACTTGTTTGGGTTAAATAGT 2321 AAGTGAATTGTAAACAATTTAGAAGTTTTTTGTTCAGCACACAAGAACACTTCTGTTACAGATTCTCTCTGACAGAAATT 2401 GTTATTTTGGGGTTTATAGATTATAGAGGGAAAAGTTAGATCACTTGGAAAAACCTAACTCTCATGTTCAGTAACTTGAG 2481 TATAGAATTTATACCACAATTTATCTTCAATAAGGAACCTACATGAACTTAATCAGTTATCTGTAGTTTTTGCAAGGCAT 2561 TAGAAAAAATTTCACAATTACAGAGGACTGAAAATGTGATTTCAACCGGCTAGTCTAGTTGTTGAATGTCCAGTCACATT 2641 ACACATAGTCCTTTGTGAACTTATTTGTGAAGGGAGTTCACTTTTTATGTACATACGTGTATATTTCCTTGTGTAATATA 2721 AAGCAGATGGTTATTAGTATTTTAGTTCTTTCAAGTTTAAATTATTCAATTGCTAGACATCACAGAAATTAGTATATTTA 2801 AGAATTTATTATAAAGCTCCTCTACAACTTTTAAAGGTGAGAGGGTCTATTATGATTTTTTTATAAAATCAAACAGCATG 2881 ATTTAGAACGTCAGTCTTCTACTTAAAATGTGTCTATATTCATGGTATTTCCATTCAGTGTAGATGGTAAGGAAAACATC 2961 TAGTCATTAAAGATTTACTTATAGCAGACTCCAGAACACTACCTACAATGGGGTTTCAGTGACTAGAAATCTTGAAGGTT 3041 TATGATTGCATCAAATTGAGCCTGTACTAATATCTAAATATCTGCTCTTATGTTCTGCTTTATCCCTTGGGATTACCTTC 3121 TAAGGTTTGGTCACACCAGCAAACTGAAACAGATCTTAATGTACATAAAAAATTTATACTAATATTACTCATCTGTGTTA 3201 CAGTATTTTGAAAAATGTTTCAGGTGTCATCTAGTCGTCTTTCATGGGTGTGATTAGTTACAAATGTTATGCTTATGTTT 3281 TCATACTTAATATCAAGCTTTCTTTGTACCTTACAAGATAGTATTTTTGGTTCTAAAAAAAACAAGCAAACTTCATTTTT 3361 GTAGTATCCAGAAATTACCTGGAGTCAGTATTTTTATTCGCCTTCTAGAACTTGTGATCCACACATCACCCATTTATATT 3441 AGTGGTAAAATTATCTGCTAAAATCTAATTGTAAGAAAGGCTTACCTTCTGTCATCAAGTGATTGTATCATCCTGGATCG 3521 TCATTTCCAAGGAACTAGCCTTTCTTTTCCTAAGCGTCTGTATGTGTTCTAAAACTTCCAGTATATATTTATAGAACTTA 3601 GAAAAAATGTTACATTATTCAGAGTAGCAAGTCTTACTGGAGTACCTATGTTTGTTTTCTTGGTTTTTATTTTTTTTTAA 3681 GTTTAAAAGTAGTAATTAAACCTATATTTTGTGATTGTTTCCTGGTCTGTGTTTTTAAATTCCTTTCCTTCAGTTTTCCT 3761 CATGAAGATGTTTCAGATACTGAATTTGTTTAGACATTGAATGACTTTGTTAAAGGCACAATTAATCACATTGGTTGTAC 3841 TCTGAAGACAGACTTCTTTAAAAAAAAAATAAACAATTTAAAACAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000380515.3 | 3UTR | UCAAGUUUAAAUUAUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
116 hsa-miR-488-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT005899 | POMC | proopiomelanocortin | 3 | 1 | ||||||||
MIRT038008 | CYP2E1 | cytochrome P450 family 2 subfamily E member 1 | 1 | 1 | ||||||||
MIRT054483 | SLC39A8 | solute carrier family 39 member 8 | 2 | 1 | ||||||||
MIRT058884 | C11ORF58 | chromosome 11 open reading frame 58 | 2 | 2 | ||||||||
MIRT061194 | MED17 | mediator complex subunit 17 | 2 | 2 | ||||||||
MIRT167237 | TMEM167A | transmembrane protein 167A | 2 | 2 | ||||||||
MIRT188343 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT218170 | MRPL18 | mitochondrial ribosomal protein L18 | 2 | 2 | ||||||||
MIRT218297 | C6ORF120 | chromosome 6 open reading frame 120 | 2 | 2 | ||||||||
MIRT263337 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT294633 | ZNF548 | zinc finger protein 548 | 2 | 2 | ||||||||
MIRT305053 | SRPRB | SRP receptor beta subunit | 2 | 6 | ||||||||
MIRT306846 | FYTTD1 | forty-two-three domain containing 1 | 2 | 2 | ||||||||
MIRT442753 | NRIP3 | nuclear receptor interacting protein 3 | 2 | 2 | ||||||||
MIRT443955 | S1PR2 | sphingosine-1-phosphate receptor 2 | 2 | 2 | ||||||||
MIRT444032 | SYNM | synemin | 2 | 2 | ||||||||
MIRT444519 | WWTR1 | WW domain containing transcription regulator 1 | 2 | 2 | ||||||||
MIRT444569 | UNC5C | unc-5 netrin receptor C | 2 | 2 | ||||||||
MIRT444779 | ECE1 | endothelin converting enzyme 1 | 2 | 2 | ||||||||
MIRT445195 | FAXC | failed axon connections homolog | 2 | 2 | ||||||||
MIRT445345 | FAM169A | family with sequence similarity 169 member A | 2 | 2 | ||||||||
MIRT445539 | TBC1D8 | TBC1 domain family member 8 | 2 | 2 | ||||||||
MIRT446058 | RABIF | RAB interacting factor | 2 | 2 | ||||||||
MIRT446358 | EFCAB6 | EF-hand calcium binding domain 6 | 2 | 2 | ||||||||
MIRT446486 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT446973 | CARKD | NAD(P)HX dehydratase | 2 | 2 | ||||||||
MIRT446984 | MOB1B | MOB kinase activator 1B | 2 | 2 | ||||||||
MIRT446987 | TMEM9B | TMEM9 domain family member B | 2 | 2 | ||||||||
MIRT447376 | AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | 2 | 2 | ||||||||
MIRT447857 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT448077 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 2 | ||||||||
MIRT448970 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT449072 | RPS15A | ribosomal protein S15a | 2 | 2 | ||||||||
MIRT449200 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT449459 | HAT1 | histone acetyltransferase 1 | 2 | 2 | ||||||||
MIRT449588 | PCDHA6 | protocadherin alpha 6 | 2 | 2 | ||||||||
MIRT449885 | ZNF621 | zinc finger protein 621 | 2 | 2 | ||||||||
MIRT449892 | C11orf34 | placenta expressed transcript 1 | 1 | 2 | ||||||||
MIRT450669 | SGIP1 | SH3 domain GRB2 like endophilin interacting protein 1 | 2 | 2 | ||||||||
MIRT450866 | GPR107 | G protein-coupled receptor 107 | 2 | 2 | ||||||||
MIRT450881 | EIF6 | eukaryotic translation initiation factor 6 | 2 | 2 | ||||||||
MIRT455373 | AAED1 | AhpC/TSA antioxidant enzyme domain containing 1 | 2 | 2 | ||||||||
MIRT458266 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT464839 | RPS27A | ribosomal protein S27a | 2 | 12 | ||||||||
MIRT465335 | TPM3 | tropomyosin 3 | 2 | 4 | ||||||||
MIRT467939 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT468719 | SDC4 | syndecan 4 | 2 | 2 | ||||||||
MIRT469844 | PXK | PX domain containing serine/threonine kinase like | 2 | 8 | ||||||||
MIRT474545 | KLHDC3 | kelch domain containing 3 | 2 | 2 | ||||||||
MIRT480700 | BRPF1 | bromodomain and PHD finger containing 1 | 2 | 2 | ||||||||
MIRT482087 | ALG8 | ALG8, alpha-1,3-glucosyltransferase | 2 | 2 | ||||||||
MIRT491225 | KCNA5 | potassium voltage-gated channel subfamily A member 5 | 2 | 2 | ||||||||
MIRT497790 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 2 | ||||||||
MIRT497831 | GPR26 | G protein-coupled receptor 26 | 2 | 2 | ||||||||
MIRT497910 | HERC2 | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 2 | 2 | ||||||||
MIRT498428 | DDX39A | DExD-box helicase 39A | 2 | 2 | ||||||||
MIRT499196 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT500396 | ZNF281 | zinc finger protein 281 | 2 | 6 | ||||||||
MIRT501523 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 10 | ||||||||
MIRT504445 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT505270 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT508584 | CCDC115 | coiled-coil domain containing 115 | 2 | 12 | ||||||||
MIRT509269 | NPM3 | nucleophosmin/nucleoplasmin 3 | 2 | 4 | ||||||||
MIRT512466 | CCDC149 | coiled-coil domain containing 149 | 2 | 2 | ||||||||
MIRT513534 | PRDM2 | PR/SET domain 2 | 2 | 4 | ||||||||
MIRT514218 | ZNF83 | zinc finger protein 83 | 2 | 4 | ||||||||
MIRT518526 | FLCN | folliculin | 2 | 6 | ||||||||
MIRT524841 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT524855 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 4 | ||||||||
MIRT525048 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT528635 | SENP6 | SUMO1/sentrin specific peptidase 6 | 2 | 2 | ||||||||
MIRT529557 | SNRNP48 | small nuclear ribonucleoprotein U11/U12 subunit 48 | 2 | 2 | ||||||||
MIRT532319 | GHSR | growth hormone secretagogue receptor | 2 | 2 | ||||||||
MIRT534232 | SLC25A16 | solute carrier family 25 member 16 | 2 | 2 | ||||||||
MIRT534254 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT536223 | LRRC41 | leucine rich repeat containing 41 | 2 | 2 | ||||||||
MIRT537658 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT537795 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 2 | ||||||||
MIRT540404 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 2 | 2 | ||||||||
MIRT544563 | POLDIP3 | DNA polymerase delta interacting protein 3 | 2 | 2 | ||||||||
MIRT546045 | VPS4B | vacuolar protein sorting 4 homolog B | 2 | 2 | ||||||||
MIRT546846 | RAB4A | RAB4A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT548480 | EEF2 | eukaryotic translation elongation factor 2 | 2 | 2 | ||||||||
MIRT549337 | ARF6 | ADP ribosylation factor 6 | 2 | 2 | ||||||||
MIRT550855 | SNAP47 | synaptosome associated protein 47 | 2 | 4 | ||||||||
MIRT551607 | ZNF267 | zinc finger protein 267 | 2 | 2 | ||||||||
MIRT553222 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT553874 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT557956 | FAM222B | family with sequence similarity 222 member B | 2 | 2 | ||||||||
MIRT559264 | BAG4 | BCL2 associated athanogene 4 | 2 | 4 | ||||||||
MIRT562245 | GRWD1 | glutamate rich WD repeat containing 1 | 2 | 2 | ||||||||
MIRT563184 | YDJC | YdjC chitooligosaccharide deacetylase homolog | 2 | 2 | ||||||||
MIRT563834 | SMDT1 | single-pass membrane protein with aspartate rich tail 1 | 2 | 2 | ||||||||
MIRT563967 | RAB6A | RAB6A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT564808 | ZBTB21 | zinc finger and BTB domain containing 21 | 2 | 2 | ||||||||
MIRT565188 | TSHZ1 | teashirt zinc finger homeobox 1 | 2 | 2 | ||||||||
MIRT565549 | SMG1 | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | 2 | 2 | ||||||||
MIRT566969 | LBR | lamin B receptor | 2 | 2 | ||||||||
MIRT570926 | ZNF284 | zinc finger protein 284 | 2 | 2 | ||||||||
MIRT612283 | ZMAT3 | zinc finger matrin-type 3 | 2 | 2 | ||||||||
MIRT612695 | PKNOX1 | PBX/knotted 1 homeobox 1 | 2 | 2 | ||||||||
MIRT625293 | ZNF619 | zinc finger protein 619 | 2 | 2 | ||||||||
MIRT628496 | LINS | lines homolog 1 | 2 | 2 | ||||||||
MIRT640282 | FAM169B | family with sequence similarity 169 member B | 2 | 2 | ||||||||
MIRT647212 | CYP2U1 | cytochrome P450 family 2 subfamily U member 1 | 2 | 2 | ||||||||
MIRT654668 | PSMB5 | proteasome subunit beta 5 | 2 | 2 | ||||||||
MIRT657516 | HAS2 | hyaluronan synthase 2 | 2 | 2 | ||||||||
MIRT670337 | C1orf106 | chromosome 1 open reading frame 106 | 2 | 4 | ||||||||
MIRT702010 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT704253 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT710205 | ENAH | ENAH, actin regulator | 2 | 2 | ||||||||
MIRT712126 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT714890 | COQ10B | coenzyme Q10B | 2 | 2 | ||||||||
MIRT716588 | PAX6 | paired box 6 | 2 | 2 | ||||||||
MIRT720810 | CIAO1 | cytosolic iron-sulfur assembly component 1 | 2 | 2 | ||||||||
MIRT724953 | AHCY | adenosylhomocysteinase | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|